Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carwin Pharmaceutical Associates was a specialty pharmaceutical company that focused on the marketing and distribution of prescription respiratory and allergy medications. Based in Hazlehurst, Georgia, the company managed a portfolio of branded combination products designed to treat symptoms of the common cold, cough, and allergic rhinitis. Key products in their lineup included Carbaphen, Z-Tuss, and C-Phen, which typically combined antihistamines, decongestants, and antitussives. The company operated primarily in the United States market before being acquired by PruGen Pharmaceuticals in 2014. Following the acquisition, its respiratory assets were integrated into PruGen's broader specialty pharmaceutical portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carwin Pharmaceutical Associates.